The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The suggestion that somebody may have mental health problems and needs help I found shocking. In my relatively long life I have known several suicide victims and others with mental health issues. The way to help is NOT some random poster on a bulletin board making a diagnosis.
I was one of four retail investors who attended the AGM in June last year and I reported back to this board.
I raised the question of cash and Tim McC swatted back with 'No we need any' and then talked about tax losses etc After the Q and A I was approached by several Directors all saying that with the US deal in the bag this put IMM in a strong position to get up front payments for a ROTW deal for LUPUS and similarly for CIDP. A few weeks later another Lanstead deal was announced.
We were also told that IMM would be more forthcoming in regularly keeping shareholders up to date. Clearly this has not happened. I have asked the company about cash flow issues and been told that information will be available at the time of publishing the Annual Accounts in late April.
INC in which IMM invested £2.5m of it's money is now worth less than £1m-but look s promising. Tim McC is Chairman ad gave an enthusiastic interview recently, has a substantial shareholding himself with more warrants issued recently. I wonder if he is spreading himself to thin-he is after all CEO of IMM and responsible for driving deals through.
Clearly with 1m shares I still have faith in the fundamentals-but I would like to see more progress and also some statement from the company about cash flow-where I agree. there is room for doubt given the nature of the Lanstead deal.
To return to the mental health issue-I intend to report this post-it has no place here.
GLA
The take up by Directors was low-only Lisa invested.
This is getting pathetic.... from 190p to less than a penny.... that's all you need to know... they have been working g on lupusor for at least 20yrs... how long does a drug take to get approval... sadly my pipe dream will soon come to an end prove what a load of muppets we have all been .. even the really clever ones... we will all receive the same fate.... just lucky to have not to have lost more than I did
" the substantial deferred tax assets amounting to nearly £50 million."
Alex
moving on..
I just wanted to ask you about that tax asset ... in the H1 report the current tax asset is £624,429
so I wasn't sure where your c.£50m figure comes from
and I wondered if your £50m instead referred to the carrying value of the £41m investment in subsidiaries and £14m receivables due which are dependent on a number of things occurring , and would need a provision if they didn't ??
could you just clarify, please
Sad that a company can treat its shareholders this way are they going to put final nail in coffin when hits 0.01 . Total silence
Another con company, run by theives. My £12k gone. Fuk.
This will never go up again.
Alex
your comment was misleading ..you missed half of what was needed out....and there is nothing you can write that changes that ....and everything you say about potential has been discussed and people are well aware of ....
" ...with the imminent update on the Phase 3 Lupuzor study by Simbec-Orion "
how do you know it is imminent .... not speculating are you?
" Finally, highlighting factual inaccuracies, ignorance, misleading affirmations or speculative assertions in investment discussions is not bullying "
I repeat and you clearly wish to deflect attention from what I said ...
repeated insults is bullying is what I said ... so no need to keep repeating yourself to deflect from that
All well and good using fancy language, Adastra and Oscar used fancy words all the down from 5p… R&D expenditure was £800k in the previous 6 months, admin costs were £400k. In the placing they received £480k in total, the £1m was a death spiral agreement over 24 months at 2.6p benchmark current price is 1p. IMO they are definitely not well funded into 2024, anyway we shall soon see who is right not that it really matters but ignore price action at your peril and that will be my final remark
Alex
As a long term investor for over 8 years now with 3 million shares at an average of 10p I have posted regularly on the positives of Immupharma in terms of its upcoming 2 Phase 3 trials , its deferred tax losses, its debt free balance sheet and its French scientific operations , low cost management structure, valuable patents and its potentially lucrative investment in Incanthera et al.
I have also referenced the growth of the Alora group under the leadership of Art Deas with its 6 subsidiary companies , including our Lupuzor partner Avion and its valuation of over $1 billion .
Alora has already invested £1.1m in Immupharma at 11p and may be interested in a further investment now that the Lupuzor trial is about to commence.
However I have stressed to Lisa that radio silence from the company is having a hugely negative effect on investor confidence and allowing small trades to drive the SP down.
Hopefully the company has some positive news in the pipeline to assuage our concerns because a requirement for an additional funding of £1/2 million is petty cash to the interested parties here including the Alora Group.
Lisa is very approachable as the company's IR contact so I urge investors to contact her.
ATB
This is giving false hope. Placing is on the way, Mr Market knows
Pokerchips,
Your assertion that my comments were misleading is false and overlooks the substantial, verifiable information provided by ImmuPharma through its recent RNS announcements, on which I've based my opinions. Let's address your points with specifics:
ImmuPharma's recent fund-raising efforts, securing £1.35 million through subscriptions and a retail offer, signal robust investor faith. This move, complemented by Director Lisa Baderoon's increased stake, highlights confidence from within. CEO Tim McCarthy has been transparent about the company's pathway to financial stability through 2024, emphasising cost minimisation and strategic resource allocation.
The strategy to explore partnerships for Lupuzor's distribution outside the US is a forward-looking approach, aiming to unlock long-term revenue streams. These discussions promise not just immediate financial relief but also a broader market presence for our flagship product, Lupuzor.
However, the current share price, now hovering around 1.165p, impacts the immediate financial benefits from the Lanstead agreement. Yet, this scenario might pivot positively with the imminent update on the Phase 3 Lupuzor study by Simbec-Orion. A positive outcome here could significantly uplift the company's valuation, demonstrating the potential misalignment between the current share price and ImmuPharma's intrinsic value.
Regarding our market capitalisation, currently at approximately £4.6m, it appears extremely modest against the backdrop of ImmuPharma's ambitious projects and strategic partnerships, notably with Avion and the substantial deferred tax assets amounting to nearly £50 million. This disparity often arises from market dynamics not fully reflecting the underlying value driven by scientific progress and strategic partnerships aimed at realising the full potential of our pipeline.
The upcoming update from Simbec-Orion on the Phase 3 Lupuzor study could be a pivotal moment, recalibrating perceptions and potentially the company's market valuation. It's a reminder that the share price and market capitalisation do not always mirror a company's foundational strengths or future prospects, especially in a sector as volatile and forward-looking as biotech.
Finally, highlighting factual inaccuracies, ignorance, misleading affirmations or speculative assertions in investment discussions is not bullying but a necessary part of maintaining an informed and rational discourse. The detailed announcements from ImmuPharma provide a solid foundation for such discussions, ensuring that debates are informed by the latest and most accurate company information. Moreover, for those genuinely invested in understanding ImmuPharma's current position and future direction, reaching out directly to the company for further insights or clarifications remains an open channel.
Scoredagainsteps,
Whilst IMM cannot control the SP , their actions or Inactions have contributed to the decline..imo
Whilst most of the comments on this board are directed on 'finance ' i would really like to see some movements in the 'science '
The lack of any updates on clinical trials IS more worrying to me than any 'future ' placings, tbh
Alexbottlier - fair enough to disagree with lambo, but all your toing & froing is little more than a smokescreen IMHO.
Assuming he's wrong, you STILL haven't explained why IMM's share price has more than halved over the past year, with almost consistently downward momentum in recent months.
Brushing this uncomfortabke fact aside with the following flimsy excuse doesn't really cut it I'm afraid: "It's important to remember that the current trajectory of ImmuPharma's share price doesn't always reflect its true value or potential, especially considering the volatility often seen in the AIM market. Short-term market dynamics and speculative trading can heavily influence stock prices, sometimes obscuring the company's long-term outlook."
The same argument could easily be applied to many a company that subsequently went bust.
I know you go on to highlight "key partnerships with Avion and Simbec-Orion, alongside efforts to reduce operational costs and secure funding". Which is all well & good.
But my question remains. If everything's really so fine & dandy, how come there's almost CONSTANT downward pressure?
" let's ensure our contributions are grounded in substance rather than unfounded and misleading comments"
Alex
Then I suggest that you set an example as your comment this morning .... was misleading...as you missed half of the comment made by Tim with regards to " financial sustainability through 2024" ..where he made it clear that his projections regarding financial stability through 2024 were dependent on Landstead providing certain levels of monthly cash , amounts of which were dependent on the share price ... Tim is like that he covers his comments with little added extras , just as he did with his definition of what defines the start of the trial , which many posters missed
" Let's set the record straight: ImmuPharma has strategically streamlined operations to ensure financial sustainability through 2024, as detailed in our recent updates."
" Exposing ignorance and groundless comments is not bullying; it's simply shedding light on reality "
you dont know the current cash level in the company and you dont know if another Landstead Agreement will come after one ends in March ....so.... where Lambo uses actual cash burn figures and makes an opinion ..it is based on some kind of reality ....even though he does often repeat himself and needs telling when he tries to state opinion as fact ....
repeatedly insulting people is bullying , not the comments on their opinion ..no confusion there
Pokerchips, while I appreciate your concern, let's not confuse stating the obvious with insults. Exposing ignorance and groundless comments is not bullying; it's simply shedding light on reality. If you find discomfort in truth, perhaps it's worth pondering why. As for discussions, I'm open to constructive debates, but let's ensure our contributions are grounded in substance rather than unfounded and misleading comments. Let's raise the bar of discourse and be constructive, I just got tired of reading nonsense comments every day.
Alex
insulting people in the manner you have is bullying and shows ignorance on your part ..not a good look
how anyone would want to discuss with a poster who behaves in that manner is ..well ..you will find yourself out there talking to yourself
Lambo, instead of addressing the substance of the discussion, you seem fixated on nonensense trivialities. I'm still awaiting a constructive argument from you to engage in a meaningful debate. Let's focus on the matters at hand rather than getting sidetracked.
Pokerchips, exposing ignorance is not bullying; it's simply stating the truth. If you find it uncomfortable, perhaps it's time for some introspection. I'm still waiting for a constructive argument from you to contribute meaningfully to the discussion.
Alex
your posts come across as controlling and bullying , attempting to use insults as an attempt to silence others
that does not give a good impression and hardly gives an impression of "wisdom" and indicates "folly" in terms of the way you go about things
Donavon you’ve forget to change your account back to Alex lol, oh dear it appears we have a multi ID spammer
Pokerchips, rather than brushing off Warren Buffett's quotes, maybe you should've given more thought to the other one: "When ignorance finds a friend, it doesn't become wisdom; it only multiplies folly." It seems fitting considering your support for Lambo's misguided remarks.
Wow
After months of minimal discussion , the board has ignited all of a sudden with contributions from new posters some of whom suggest they are very close to the company in their analysis and rebuttal of Lambo's
repeated claims of another death spiral placing or worse.
Surely Uncle Tim is not involved in this sudden explosion of chat!!
Hopefully the share price can mirror the volume of postings and get moving upwards
At the moment the market is not interested as this deathly silence from the company continues.
" Lambo, we are waiting for some constructive discussions, please stop posting silly comments."
says the guys who posts
"The stock market is designed to transfer money from the Active to the Patient." - Warren Buffett
"Be fearful when others are greedy, and be greedy when others are fearful." - Warren Buffett
no doubt YOU are the one determining what is silly and constructive then ??
Donovan, I concur with your perspective. Lambo's proposal is bold, but I respectfully decline. I prefer stimulating conversations. As for the bet, I accept it too and if there's no placing by the specified date, Lambo, has to agree to exit this board. Lambo, we are waiting for some constructive discussions, please stop posting silly comments.
Lambo, while your proposal has a certain audacity, I must respectfully decline. I prefer to share drinks with those whose company I find intellectually stimulating, and frankly, your track record suggests our conversation might be less than inspiring. Maybe you could invite your newfound fan; you two seem to match quite well. Who knows, perhaps you could become more than just friends.
Regarding your wager, let's streamline things. I accept but if there's no placing by the specified date, kindly agree to quietly exit this board. Let's keep our discussions focused on substance rather than entertaining frivolous bets.
Definitely from Imperial that’s why he’s taking it so personally.
At least you know where to find him, Lambo